Christopher P. Kalnin - 25 Mar 2026 Form 4 Insider Report for BKV Corp (BKV)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: BKV
Reported as of: 25 Mar 2026
Net transaction value: -$3,005,790
SEC form: 4
Accepted by SEC: 25 Mar 2026, 17:16:48 UTC
Prior SEC filing: 12 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen Lenox, attorney-in-fact

Key filing fact

Christopher P. Kalnin filed Form 4 for BKV Corp (BKV) on 25 Mar 2026.

Key facts

This page summarizes Christopher P. Kalnin's Form 4 filing for BKV Corp (BKV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Mar 2026, 17:16.

Change

Previous filing in this sequence was filed on 12 Mar 2026.
Current net transaction value: -$3,005,790.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001953932 Primary reporting owner

Kalnin Christopher P

Relationship: Chief Executive Officer, Director
Address: 1200 17TH STREET, SUITE 2100, DENVER
Signature: /s/ Kathleen Lenox, attorney-in-fact
Signature date: 25 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BKV transaction

Common Stock

Sale

Transaction value: $3,005,790
Shares: -100,000
Change %: -7.7%
Price: $30.06
Shares after: 1,197,243
Date: 25 Mar 2026
Ownership: Direct
Footnotes: F1, F2

BKV holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 875,754
Date: 25 Mar 2026
Ownership: By Spouse

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.

Footnote F2

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.